Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice

Neurobiology of Aging

Volumn 22, Issue 3, 2001, Pages 377-385

  Gordon, Marcia N ^a   King, David L ^a   Diamond, David M ^a   Jantzen, Paul T ^a   Boyett, Kristal V ^a   Hope, Caroline E ^a   Hatcher, Jaime M ^a   DiCarlo, Giovanni ^a   Gottschall, W Paul E ^a   Morgan, Dave ^a   Arendash, Gary W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

A deposition; Alzheimer's disease; Amyloid load; Learning and memory; Radial arm water maze; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; LEARNING TEST; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MEMORY; MICE; MICE, TRANSGENIC; MUTATION; NEURODEGENERATIVE DISEASES; PEPTIDE FRAGMENTS; PRESENILIN-1; SENILE PLAQUES; SPACE PERCEPTION;

EID: 0034988318     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00249-9     Document Type: Article

References (51)

1. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein (APP), and presenilin 1 (PS1) transgenes
2. Evidence for glial-mediated inflammation in APPsw transgenic mice
3. The association between quantitative measures of dementia, and of senile change in the cerebral grey matter of elderly subjects
4. Electroconvulsive shock, and lidocaine reveal rapid consolidation of spatial working memory in the water maze
5. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1, and amyloid precursor protein
6. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro, and in vivo
7. Radial maze in the water tank: An aversively motivated spatial working memory task
8. Neuron loss in APP transgenic mice
9. Impaired synaptic plasticity, and learning in aged amyloid precursor protein transgenic mice
10. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells, and transgenic mice
11. Beta-amyloid deposition, and other measures of neuropathology predict cognitive status in Alzheimer's disease
12. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein
13. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
14. Tau,paired helical filaments, and amyloid in the neocortex: A moprhometric study of 15 cases with graded intellectual status in aging, and senile dementia of Alzheimer type
15. Subtypes, and differential laminar distributions of beta A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases
16. Beta A4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 French centenarians
17. Exposing rats to a predator impairs spatial working memory in the radial arm water maze
18. Correlations of synaptic, and pathological markers with cognition of the elderly
19. Behavioral deficits in APPV717F transgenic mice deficient for the apolipoprotein E gene
20. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein
21. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
22. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease
23. Microglial response to amyloid plaques in APPsw transgenic mice
24. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
25. Progression of neuropathology in transgenic mice expressing both amyloid precursor protein, and presenilin-1 mutations
26. Exageratted astrocyte reactivity after nigrostriatal deafferentation in the aged rat
27. Amyloid, the presenilins, and Alzheimer's disease
28. Neurofibrillary tangles in nondemented elderly subjects, and mild Alzheimer disease
29. Visual-discrimination learning ability, and beta-amyloid accumulation in the dog
30. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein, and presenilin 1 transgenes
31. Behavioral changes in transgenic mice expressing both amyloid precursor protein, and presenilin-1 mutations: Lack of association with amyloid deposits
32. Age-related CNS disorder, and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
33. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
34. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome
35. Visualization of Aβ42(43), and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
36. Amyloid precursor protein processing, and A beta42 deposition in a transgenic mouse model of Alzheimer disease
37. Behavioral characterization of PDAPP transgenic Alzheimer mice
38. Relating anatomy to function in Alzheimer's disease: Neuropsychological profiles predict regional neuropathology 5 years later
39. Progressive, and gender-dependent cognitive impairment in the APPsw transgenic mouse model for Alzheimer's disease
40. Reversal of beta-amyloid induced retention deficit after exposure to training, and state cues
41. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, and Alzheimer's disease
42. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction
43. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein, and mutant presenilin 1 transgenes
44. Vaccination with Aβ peptide prevents age-related memory deficits in an animal model of Alzheimer's disease
45. Place navigation impaired in rats with hippocampal lesions
46. Correlation between elevated levels of amyloid beta-peptide in the brain, and cognitive decline
47. Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype, and duration of disease
48. Elevated Aβ levels in Alzheimers disease brain are associated with a selective accumulation of Aβ42 in parenchymal amyloid deposits, and both Aβ40, and Aβ42 in cerebrovascular deposits
49. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
50. Physical basis of cogntive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
51. Reorganization of cholinergic terminals in the cerebral cortex, and hippocampus in transgenic mice carrying mutated presenilin-1, and amyloid precursor protein transgenes